Detection of Cryptococcus by conventional, serological and molecular methods.

Area of Science:

• Medical Mycology
• Infectious Diseases
• Diagnostic Microbiology

Background:

• Cryptococcosis incidence is rising in India, leading to significant morbidity and mortality.
• Current diagnostic methods lack sensitivity, hindering timely and effective treatment.
• Early detection is critical for managing cryptococcal infections and preventing severe outcomes.

Purpose of the Study:

• To evaluate and compare the sensitivity and specificity of conventional and rapid diagnostic methods for cryptococcosis.
• To identify the most effective diagnostic approach for cryptococcosis in an Indian population.
• To assess diagnostic performance across different sample types (CSF, serum, urine) and treatment stages.

Main Methods:

• Comparative evaluation of direct microscopy, culture, latex agglutination test (LAT), enzyme immunoassay (EIA), and polymerase chain reaction (PCR).
• Analysis of 359 samples from 52 positive patients and 30 negative controls.
• Testing performed on cerebrospinal fluid (CSF), serum, and urine, both pre-treatment and post-treatment.

Main Results:

• Polymerase chain reaction (PCR) demonstrated the highest sensitivity, followed by EIA and LAT, across all sample types and treatment phases.
• LAT, EIA, and PCR provided positive detection for extended periods post-treatment: CSF (>90 days), serum (~65 days), and urine (~45 days).
• PCR and EIA showed comparable high sensitivity and specificity in diagnosing cryptococcosis using CSF, serum, and urine samples.

Conclusions:

• Rapid diagnostic methods, particularly PCR and EIA, are highly effective for sensitive and specific cryptococcosis detection.
• These advanced techniques are crucial for improving early diagnosis and patient outcomes in high-incidence regions like India.
• The prolonged detection window of PCR and EIA aids in monitoring treatment response and disease clearance.